Marsela Jorgolli is responsible for leading Evozyne’s breakthrough technology development and automation initiative to enable cutting-edge research and stream-lined products.
She provides leadership, vision, and strategic operations to our broader team of engineers, scientists, and informaticists. Prior to joining Evozyne, Marsela led multi disciplinary research and managed cross-functional projects in R&D and Operations at Amgen. There she focused on developing and transferring analytical methods, novel technologies, and automation for large molecule discovery, hybrid modality engineering, cell engineering, and product development. She holds a Ph.D. in physics from Harvard University with a focus on innovative nano-bio technologies and methods, and a bachelor’s degree in physics from the University of Chicago.